Drug name - Lamictal Xr
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9144547 | GLAXOSMITHKLINE LLC | Oral dosage form for controlled drug release |
Sep, 2023
(11 months from now) | |
| US8637512 | GLAXOSMITHKLINE LLC | Formulations and method of treatment |
Jun, 2028
(5 years from now) | |
Drugs and Companies using LAMOTRIGINE ingredient
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 25MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 50MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 100MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 200MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 250MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
| 300MG | TABLET, EXTENDED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.